Clinical Trial Update: Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing azathioprine versus mesalazine to prevent postoperative relapse in Crohn's disease has completed. The sponsor is Dr. Falk Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Azathioprine (azathioprine)
• Mesalazine (mesalazine)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED